Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
UK: More health is associated with more cardiovascular disease (CVD) and higher triglycerides...
Read Full NewsTake 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 9, 2026.
A review of clinical trial and real-world data found no evidence that oral anticoagulants increase brain imaging abnormalities in patients treated with lecanemab or donanemab for early Alzheimer disease.
Angela Lek, PhD, chief research officer at the Muscular Dystrophy Association, provided an outlook on the 2026 MDA meeting and what clinicians should look forward to in preparation.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on epilepsy comorbidities!
Phase 3 Trial Supports Subcutaneous Anifrolumab in Systemic Lupus Erythematosus
5 Pulmonology Headlines You Missed in December 2025
Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery
1.
Approved BTK Inhibitor Without Covalent Bond for CLL.
2.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
3.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
4.
Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.
5.
Brain cancer: a Q&A session.
1.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
2.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
3.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
4.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
5.
Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Navigating the Complexities of Ph Negative ALL - Part VII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge